ALSERES PHARMACEUTICALS INC Contracts & Agreements
148 Contracts & Agreements
- Business Finance (63 contracts)
- Human Resources (22)
- Intellectual Property (9)
- Real Estate (2)
- Uncategorized (52)
- 10.7 PROMISSORY NOTE (Filed With SEC on July 23, 2012)
- PROMISSORY NOTE (Filed With SEC on June 13, 2012)
- PROMISSORY NOTE (Filed With SEC on May 8, 2012)
- Navidea Biopharmaceuticals Enters into Option Agreement to LicenseParkinsons Disease Imaging Agent Licensing would add second neuro-imaging candidate to growing... (Filed With SEC on January 25, 2012)
- PROMISSORY NOTE (Filed With SEC on December 14, 2011)
- PROMISSORY NOTE (Filed With SEC on October 19, 2011)
- PROMISSORY NOTE September 8, 2011 $100,000 Hopkinton, Massachusetts (Filed With SEC on September 12, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on August 29, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on July 29, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on July 18, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on June 24, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on June 6, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on May 11, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on May 4, 2011)
- PROMISSORY NOTE April 1, 2011 $170,000 Hopkinton, Massachusetts (Filed With SEC on April 5, 2011)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2011)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2011)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on March 22, 2011)
- Alseres Pharmaceuticals, Inc (Filed With SEC on March 10, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on February 9, 2011)
- PROMISSORY NOTE January 7, 2011$200,000 Hopkinton, Massachusetts (Filed With SEC on January 13, 2011)
- Entry into Material Definitive Agreements (Filed With SEC on December 10, 2010)
- Alseres Pharmaceuticals, Inc (Filed With SEC on November 5, 2010)
- NOTE PURCHASE AGREEMENT (Filed With SEC on September 16, 2010)
- PROMISSORY NOTE September 13, 2010 $7000,000 Hopkinton, Massachusetts (Filed With SEC on September 16, 2010)
- PROMISSORY NOTE September 7, 2010 $150,000 Hopkinton, Massachusetts (Filed With SEC on September 8, 2010)
- Entry into a Material Definitive Agreement (Filed With SEC on August 3, 2010)
- PROMISSORY NOTE $200,000 July 1, 2010 Hopkinton, Massachusetts (Filed With SEC on July 8, 2010)
- PROMISSORY NOTE June 10, 2010 $150,000 Hopkinton, Massachusetts (Filed With SEC on June 11, 2010)
- PROMISSORY NOTE April 20, 2010 $200,000 Hopkinton, Massachusetts (Filed With SEC on April 21, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- Molecular imaging program focused on the diagnosis of i) Parkinsonian Syndromes, or PS, including Parkinsons Disease, or PD, and ii) Dementia with Lewy Bodies, or DLB (Filed With SEC on March 31, 2010)
- PROMISSORY NOTE February 26, 2010 $100,000 Hopkinton, Massachusetts (Filed With SEC on March 4, 2010)
- PROMISSORY NOTE January 22, 2010 $300,000 Hopkinton, Massachusetts (Filed With SEC on January 28, 2010)
- See Exhibit Index attached hereto (Filed With SEC on December 28, 2009)
- See Exhibit Index attached hereto (Filed With SEC on December 28, 2009)
- EX-10.3 Securities Purchase Agreement dated August 11, 2009 (Filed With SEC on November 16, 2009)
- EX-10.7 Securities Purchase Agreement, dated November 4, 2009 (Filed With SEC on November 10, 2009)
- Exhibits See Exhibit Index attached hereto (Filed With SEC on October 2, 2009)
- EX-10.7 - Securities Purchase Agreement, dated September 10, 2009, by and between the Company and Robert Gipson (Filed With SEC on September 16, 2009)
- Ex-10.7 Securities Purchase Agreement, dated August 26, 2009 (Filed With SEC on September 1, 2009)
- EX-10.2 Securities Purchase Agreement dated May 12, 2009, by and between the Company and Robert L. Gipson (Filed With SEC on August 14, 2009)
- EX-10.6 Amendment to License Agreement dated April 23, 2009 by and between the Company and BioAxone Therapeutic Inc (Filed With SEC on August 14, 2009)
- EX-10.7 Securities Purchase Agreement, dated July 23, 2009, by and between the Company and Robert Gipson (Filed With SEC on July 29, 2009)
- Ex-10.7 Securities Purchase Agreement, dated July 9, 2009 (Filed With SEC on July 13, 2009)
- Ex-10.7 Securities Purchase Agreement, dated June 10, 2009 (Filed With SEC on June 22, 2009)
- EX-10.6 SECURITIES PURCHASE AGREEMENT ROBERT L. GIPSON (Filed With SEC on May 15, 2009)
- Ex-10.1 Securities Purchase Agreement, dated April 16, 2009, by and between the Company and Robert Gipson (Filed With SEC on April 22, 2009)
- EX-10.33 Securities Purchase Agreement, dated January 8, 2009 (Filed With SEC on March 31, 2009)
- EX-10.37 Non-Employee Director Compensation Summary (Filed With SEC on March 31, 2009)
- EX-10.38 Executive Officer Compensation Summary (Filed With SEC on March 31, 2009)
- EX-10.44 Amended and Restated 1990 Non-Employee Directors' Non Qualified Stock Option Plan (Filed With SEC on March 31, 2009)
- EX-10.45 Amended and Restated Omnibus Stock Option Plan (Filed With SEC on March 31, 2009)
- EX-10.46 Amended and Restated 1998 Omnibus Stock Option Plan (Filed With SEC on March 31, 2009)
- EX-10.47 Amended and Restated 2005 Stock Incentive Plan (Filed With SEC on March 31, 2009)
- EX-4.1 Certificate of Designations, Rights and Preferences of Series F Convertible Preferred Stock (Filed With SEC on March 25, 2009)
- EX-10.1 Securities Purchase Agreement, dated March 19, 2009, by and between the Company and Robert Gipson (Filed With SEC on March 25, 2009)
- EX-10.1 SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 27, 2009)
- EX-10.2 LETTER AGREEMENT CATO BIO VENTURES (Filed With SEC on February 27, 2009)
- PROMISSORY NOTE February 11, 2009 $1,000,000 Hopkinton, Massachusetts (Filed With SEC on February 18, 2009)
- EX-10.1 Amended and Restated Employment Agreement, dated December 31, 2008, between the Company and Peter G. Savas (Filed With SEC on January 6, 2009)
- EX-10.2 Amended and Restated Employment Agreement, dated December 31, 2008, between the Company and Mark J. Pykett (Filed With SEC on January 6, 2009)
- EX-10.3 Amended and Restated Employment Agreement, dated December 31, 2008, between the Company and Kenneth L. Rice, Jr (Filed With SEC on January 6, 2009)
- Ex-10.1 Amendment No.9 to Manufacturing Agreement (Filed With SEC on December 8, 2008)
- Ex-10.1 Extension to Option Agreement, dated November 27, 2008 (Filed With SEC on December 3, 2008)
- EX-10.1 SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 25, 2008)
- EX-10.2 FORM OF WARRANT (Filed With SEC on November 25, 2008)
- EX-10.3 LETTER AGREEMENT ROBERT GIPSON (Filed With SEC on November 25, 2008)
- EXTENSION TO OPTION AGREEMENT (Filed With SEC on October 30, 2008)
- EX-10.1 Convertible Promissory Note Purchase Agreement dated June 25, 2008 (Filed With SEC on June 30, 2008)
- EX-10.1 Option Agreement dated May 2, 2008 (Filed With SEC on May 6, 2008)
- EX-10.29 Non-Employee Director Compensation Company (Filed With SEC on March 31, 2008)
- EX-10.30 Executive Officer Compensation Summary (Filed With SEC on March 31, 2008)
- EX-10.1 Third Amended Restated Convertible Promissory Note (Filed With SEC on March 20, 2008)
- EX-10.1 - Amendment No. 8 dated 12-04-2007 to Manufacturing Agreement between MDS Nordion Inc. and the Company (Filed With SEC on December 7, 2007)
- Ex-10.1 Second Amended and Restated Convertible Promissory Note Purchase Agreement, by and among the Company and the purchasers listed therein, dated August 13, 2007 (Filed With SEC on November 14, 2007)
- Ex-4.1 Specimen certificate evidencing shares of common stock (Filed With SEC on August 14, 2007)
- Ex-10.1 Stock Option Agreement dated June 5, 2007 (Filed With SEC on August 14, 2007)
- EX-10.1 FIRST AMENDMENT, EFFECTIVE MARCH 23, 2007, TO LICENSE AGREEMENT (Filed With SEC on May 15, 2007)
- EX-10.2 THIRD AMENDMENT, EFFECTIVE APRIL 1, 2007, TO LICENSE AGREEMENT (Filed With SEC on May 15, 2007)
- EX-10.3 SECOND AMENDMENT, EFFECTIVE APRIL 1, 2007, TO LICENSE AGREEMENT (Filed With SEC on May 15, 2007)
- EX-10.4 EMPLOYMENT AGREEMENT, DATED APRIL 16, 2007 FRANK BOBE (Filed With SEC on May 15, 2007)
- EX-10.30 Non-Employee Director Compensation Summary (Filed With SEC on April 2, 2007)
- EX-10.31 Executive Officer Compensation Summary (Filed With SEC on April 2, 2007)
- EX-10.52 Nonstatutory Stock Option Agreement (Peter Savas) (Filed With SEC on April 2, 2007)
- EX-10.53 Nonstatutory Stock Option Agreement (Mark Rykett) (Filed With SEC on April 2, 2007)
- EX-10.54 Nonstatutory Stock Option Agreement (Ken Rice) (Filed With SEC on April 2, 2007)
- EX-10.1 THIRD AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on March 28, 2007)
- EX-10.2 SECOND AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on March 28, 2007)
- EX-10.1 CONVERTIBLE PROMISSORY NOTE AGREEMENT (Filed With SEC on March 28, 2007)
- Ex-10.1 Second Amended and Restated Promissory Note (Filed With SEC on February 13, 2007)
- Ex-10.2 Amended and Restated Promissory Note (Filed With SEC on February 13, 2007)
- EX-10.1 License Agreement, dated December 28, 2006 (Filed With SEC on January 4, 2007)
- EX-10.1 Amendment No. 7 dated as of December 7, 2006 (Filed With SEC on December 8, 2006)
- Ex-10.1 Amended and Restated Promissory Note (Filed With SEC on November 1, 2006)
- Ex-10.2 Promissory Note (Filed With SEC on November 1, 2006)
- Ex-10.1 Consulting Agreement dated September 29, 2006 (Filed With SEC on October 4, 2006)
- EX-10.1 Exclusive License Agreement (Benowitz) (Filed With SEC on August 14, 2006)
- EX-10.2 Exclusive License Agreement (He) (Filed With SEC on August 14, 2006)
- Ex-10.3 Promissory Note (unsecured) in favor of Robert Gipson dated August 8, 2006 (Filed With SEC on August 14, 2006)
- EX-4.1 SPECIMEN CERTIFICATE EVIDENCING SHARES OF COMMON STOCK (Filed With SEC on March 31, 2006)
- EX-10.28 NON-EMPLOYEE DIRECTOR COMPENSATION SUMMARY (Filed With SEC on March 31, 2006)
- EX-10.29 EXECUTIVE OFFICER COMPENSATION SUMMARY (Filed With SEC on March 31, 2006)
- EX-10.48 EMPLOYMENT AGREEMENT 3/31/06 - SAVAS (Filed With SEC on March 31, 2006)
- EX-10.49 EMPLOYMENT AGREEMENT 3/31/06 - PYKETT (Filed With SEC on March 31, 2006)
- EX-10.50 EMPLOYMENT AGREEMENT 3/31/06 - RICE (Filed With SEC on March 31, 2006)
- EX-10.51 STOCK OPTION AGREEMENT 1/6/06 - SAVAS (Filed With SEC on March 31, 2006)
- EX-10.52 STOCK OPTION AGREEMENT 1/6/06 - PYKETT (Filed With SEC on March 31, 2006)
- EX-10.53 STOCK OPTION AGREEMENT 1/6/06 - RICE (Filed With SEC on March 31, 2006)
- EX-10.54 FORM OF INCENTIVE STOCK OPTION (Filed With SEC on March 31, 2006)
- EX-10.55 FORM OF NON-STATUTORY STOCK OPTION (Filed With SEC on March 31, 2006)
- AGREEMENT (Filed With SEC on November 14, 2005)
- - 1 - (Filed With SEC on November 14, 2005)
- ARTICLE I. DEFINITIONS (Filed With SEC on November 14, 2005)
- - 2 - (Filed With SEC on November 14, 2005)
- WITNESSETH: (Filed With SEC on November 14, 2005)
- SEVERANCE AND SETTLEMENT AGREEMENT AND RELEASE (Filed With SEC on August 15, 2005)
- CONSULTING AGREEMENT (Filed With SEC on August 15, 2005)
- LEASE (Filed With SEC on August 15, 2005)
- W I T N E S S E T H: (Filed With SEC on August 15, 2005)
- AMENDMENT TO LICENSE AGREEMENT (Agreement number 2639; CMCC 600) (Filed With SEC on August 15, 2005)
- W I T N E S S E T H: (Filed With SEC on August 15, 2005)
- Boston Life Sciences, Inc. (Filed With SEC on May 16, 2005)
- Boston Life Sciences, Inc. (Filed With SEC on May 16, 2005)
- AMENDMENT NO. 1 TO WARRANT (Filed With SEC on March 31, 2005)
- AMENDMENT NO. 2 TO WARRANT (Filed With SEC on March 31, 2005)
- AMENDMENT NO. 1 TO WARRANT (Filed With SEC on March 31, 2005)
- AMENDMENT NO. 1 TO WARRANT (Filed With SEC on March 31, 2005)
- BOSTON LIFE SCIENCES, INC. Restructuring Agreement (Filed With SEC on March 31, 2005)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on March 31, 2005)
- AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 31, 2005)
- Boston Life Sciences, Inc. (Filed With SEC on March 31, 2005)
- Boston Life Sciences, Inc. (Filed With SEC on March 31, 2005)
- Non-Employee Director Compensation Summary (Filed With SEC on March 31, 2005)
- Executive Officer Compensation Summary (Filed With SEC on March 31, 2005)
- LEASE (Filed With SEC on March 31, 2005)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on March 31, 2005)
- AMENDMENT NO. 5 TO RIGHTS AGREEMENT (Filed With SEC on March 15, 2005)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 30, 2004)
- INDEMNITY AGREEMENT (Filed With SEC on March 30, 2004)